---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-100980"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:49:11.489499+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Incannex Healthcare gets Nasdaq bid price compliance extension to April 20, 2026

## Summary
- Received second 180-day grace period from Nasdaq until April 20, 2026 to regain $1 minimum bid price.
- Failed bid price requirement; transferred to Nasdaq Capital Market on July 10, 2025.
- Must close at $1 or above for 10 consecutive business days during extension to comply.
- Company intends to cure deficiency via reverse stock split if necessary.
- Listing on Nasdaq Capital Market continues; no immediate delisting effect.

## SEC filing metadata
- accession: 0001213900-25-100980
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390025100980/0001213900-25-100980-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390025100980/ea0262074-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-100980
- JSON: https://secwatch.observer/filing/0001213900-25-100980.json
- Plain text: https://secwatch.observer/filing/0001213900-25-100980.txt

## Source-grounded claims
- claim_id: aceb532c5c26121896006e2d89fec70e39bc30d2
  claim: Incannex Healthcare Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5450(a)(1), 5810(c)(3)(A)).
  evidence_excerpt: April 20, 2026 (the “Second Grace Period”) to regain compliance with the Bid Price Requirement. According to the notification from Nasdaq, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, with the exception of the Bid Price Requirement, and (ii) the Company’s written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If at any time during this Second Grace Period
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873875/000121390025100980/0001213900-25-100980-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.